311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster II

Trial in progress Study design of a randomized phase 3 trial evaluating the efficacy and safety of mezagitamab TAK 079 compared with placebo in adults with chronic primary immune thrombocytopenia

Real world study on thrombopoietin receptor agonists combined with rituximab in the treatment of Relapsed Refractory primary immune thrombocytopenia

Efficacy and safety of hetrombopag in the treatment of Pediatric immune thrombocytopenia A Real World Observational Study

Treatment strategies and outcomes in pediatric patients with immune thrombocytopenia ITP undergoing surgical procedures A multicenter study

Impact of obesity on response to first line treatment in primary immune thrombocytopenia data from Latin America population

A prospecitive multicenter study of chidamide in adult patients with refractory primary immune thrombocytopenia

Dose dense rituximab for high risk children and adolescents with newly diagnosed acute immune thrombocytopenic purpura ITP NCT04323748

Shared decision making for immune thrombocytopenia ITP treatment Data from the ITP natural history study registry

Efficacy and safety of romiplostim N01 for second line treatment of pediatric immune thrombocytopenia A multicenter prospective observational study

Interim report of a phase 1 2 study of ESG206 in patients with refractory or relapsed primary immune thrombocytopenia

Measuring success by different rulers Heterogeneity in definition of outcomes in immune thrombocytopenia trials

The platelet variability index tool to determine the likelihood of immune thrombocytopenia ITP User testing and tool refinement

Clonal T large granular lymphocytes LGL in chronic relapsing remitting and refractory immune thrombocytopenia

Long term remissions in refractory ITP patients by daratumumab

Assessment of thrombotic risk and pathophysiological mechanisms of splenectomy associated hypercoagulability in patients with immune thrombocytopenia

Post operative thrombocytopenia in on versus off pump coronary artery bypass grafting

Reproductive health in patients with primary immune thrombocytopenia ITP receiving rilzabrutinib A subgroup analysis from the Phase 3 LUNA3 multicenter study